Review



anti cd16 primary antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss anti cd16 primary antibody
    Anti Cd16 Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd16+primary+antibody/CD16+Polyclonal+Antibody/pm41448306-110-17-23
    Average 94 stars, based on 10 article reviews
    anti cd16 primary antibody - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    Bioss anti cd16 primary antibody
    Anti Cd16 Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd16+primary+antibody/CD16+Polyclonal+Antibody/pm41448306-110-17-23
    Average 94 stars, based on 1 article reviews
    anti cd16 primary antibody - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    90
    Becton Dickinson primary biotin rat anti-mouse cd16/32 antibody
    A) Incidence of tumor onset in IL-15 −/− TAX-LUC mice (red line, n = 10) compared to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 21), p = 0.03 (2-tailed, paired Student’s T Test). B) Survival curve comparing IL-15 −/− TAX-LUC mice (red line, n = 13) and IL-15 +/− TAX-LUC mice (blue line, n = 14) to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 10). p = 0.006 for KO vs. WT and p = 0.02 for HET vs. WT. C) Image <t>of</t> <t>CD16/32</t> immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which the malignant large granular lymphocytes (red arrows) are stained along with an admixture of tumor infiltrating neutrophils (black arrows). Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-CD16/32 FITC (red curves). D) Image of Ly6G immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which tumor infiltrating neutrophils (black arrows) are stained. Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-Ly6G-PE (red curves). E) Image of phosho-RelA immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which many of the malignant large granular lymphocytes (red arrows) show nuclear localization as a marker of NFκB activation. F) Image of a peripheral blood smear (Wright’s stain). G) Hematoxylin and eosin stained IL-15 −/− TAX-LUC tumor section. H) Image of Ki67 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections.
    Primary Biotin Rat Anti Mouse Cd16/32 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd16+primary+antibody/anti+cd56/pmc03885672-127-35-40
    Average 90 stars, based on 1 article reviews
    primary biotin rat anti-mouse cd16/32 antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    fluidigm house primary cd16 32 144nd 93
    A) Incidence of tumor onset in IL-15 −/− TAX-LUC mice (red line, n = 10) compared to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 21), p = 0.03 (2-tailed, paired Student’s T Test). B) Survival curve comparing IL-15 −/− TAX-LUC mice (red line, n = 13) and IL-15 +/− TAX-LUC mice (blue line, n = 14) to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 10). p = 0.006 for KO vs. WT and p = 0.02 for HET vs. WT. C) Image <t>of</t> <t>CD16/32</t> immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which the malignant large granular lymphocytes (red arrows) are stained along with an admixture of tumor infiltrating neutrophils (black arrows). Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-CD16/32 FITC (red curves). D) Image of Ly6G immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which tumor infiltrating neutrophils (black arrows) are stained. Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-Ly6G-PE (red curves). E) Image of phosho-RelA immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which many of the malignant large granular lymphocytes (red arrows) show nuclear localization as a marker of NFκB activation. F) Image of a peripheral blood smear (Wright’s stain). G) Hematoxylin and eosin stained IL-15 −/− TAX-LUC tumor section. H) Image of Ki67 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections.
    House Primary Cd16 32 144nd 93, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd16+primary+antibody/Anti-Mouse+CD16%2F32+(93)-144Nd/pmc07080547__ADVS___7___1902650___s001-281-23-33
    Average 93 stars, based on 1 article reviews
    house primary cd16 32 144nd 93 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology second primary mouse monoclonal anti cd16 igg 1 antibody
    A) Incidence of tumor onset in IL-15 −/− TAX-LUC mice (red line, n = 10) compared to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 21), p = 0.03 (2-tailed, paired Student’s T Test). B) Survival curve comparing IL-15 −/− TAX-LUC mice (red line, n = 13) and IL-15 +/− TAX-LUC mice (blue line, n = 14) to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 10). p = 0.006 for KO vs. WT and p = 0.02 for HET vs. WT. C) Image <t>of</t> <t>CD16/32</t> immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which the malignant large granular lymphocytes (red arrows) are stained along with an admixture of tumor infiltrating neutrophils (black arrows). Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-CD16/32 FITC (red curves). D) Image of Ly6G immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which tumor infiltrating neutrophils (black arrows) are stained. Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-Ly6G-PE (red curves). E) Image of phosho-RelA immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which many of the malignant large granular lymphocytes (red arrows) show nuclear localization as a marker of NFκB activation. F) Image of a peripheral blood smear (Wright’s stain). G) Hematoxylin and eosin stained IL-15 −/− TAX-LUC tumor section. H) Image of Ki67 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections.
    Second Primary Mouse Monoclonal Anti Cd16 Igg 1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+cd16+primary+antibody/IgG1+Antibody/pmc03278700-96-39-53
    Average 96 stars, based on 1 article reviews
    second primary mouse monoclonal anti cd16 igg 1 antibody - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    Image Search Results


    A) Incidence of tumor onset in IL-15 −/− TAX-LUC mice (red line, n = 10) compared to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 21), p = 0.03 (2-tailed, paired Student’s T Test). B) Survival curve comparing IL-15 −/− TAX-LUC mice (red line, n = 13) and IL-15 +/− TAX-LUC mice (blue line, n = 14) to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 10). p = 0.006 for KO vs. WT and p = 0.02 for HET vs. WT. C) Image of CD16/32 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which the malignant large granular lymphocytes (red arrows) are stained along with an admixture of tumor infiltrating neutrophils (black arrows). Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-CD16/32 FITC (red curves). D) Image of Ly6G immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which tumor infiltrating neutrophils (black arrows) are stained. Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-Ly6G-PE (red curves). E) Image of phosho-RelA immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which many of the malignant large granular lymphocytes (red arrows) show nuclear localization as a marker of NFκB activation. F) Image of a peripheral blood smear (Wright’s stain). G) Hematoxylin and eosin stained IL-15 −/− TAX-LUC tumor section. H) Image of Ki67 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections.

    Journal: PLoS ONE

    Article Title: IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity

    doi: 10.1371/journal.pone.0085028

    Figure Lengend Snippet: A) Incidence of tumor onset in IL-15 −/− TAX-LUC mice (red line, n = 10) compared to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 21), p = 0.03 (2-tailed, paired Student’s T Test). B) Survival curve comparing IL-15 −/− TAX-LUC mice (red line, n = 13) and IL-15 +/− TAX-LUC mice (blue line, n = 14) to IL-15 +/+ TAX-LUC littermate control mice (black line, n = 10). p = 0.006 for KO vs. WT and p = 0.02 for HET vs. WT. C) Image of CD16/32 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which the malignant large granular lymphocytes (red arrows) are stained along with an admixture of tumor infiltrating neutrophils (black arrows). Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-CD16/32 FITC (red curves). D) Image of Ly6G immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which tumor infiltrating neutrophils (black arrows) are stained. Insets are FACS histograms of homogenates from IL-15 +/+ TAX-LUC or IL-15 −/− TAX-LUC tail tumors unstained (white curves) or stained with anti-Ly6G-PE (red curves). E) Image of phosho-RelA immunohistochemistry of IL-15 −/− TAX-LUC tumor sections in which many of the malignant large granular lymphocytes (red arrows) show nuclear localization as a marker of NFκB activation. F) Image of a peripheral blood smear (Wright’s stain). G) Hematoxylin and eosin stained IL-15 −/− TAX-LUC tumor section. H) Image of Ki67 immunohistochemistry of IL-15 −/− TAX-LUC tumor sections.

    Article Snippet: For CD16/32 staining additional blocking steps with avidin D solution (Vector Laboratories) and for 15 min at room temp, followed by biotin for 15 minutes at room temperature was included prior to incubation in primary biotin rat anti-mouse CD16/32 antibody (BD Pharmingen) overnight at 4°C.

    Techniques: Immunohistochemistry, Staining, Marker, Activation Assay

    A) Schematic representation of experimental design. RNA harvested from CD16/32 HI and CD16/32 LO cells from IL-15 +/+ and IL-15 −/− TAX-LUC tail tumors were analyzed by array. B) Profiles of gene expression changes associated with the absence of IL-15 in CD16/32 HI and CD16/32 LO tumor cell populations.

    Journal: PLoS ONE

    Article Title: IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity

    doi: 10.1371/journal.pone.0085028

    Figure Lengend Snippet: A) Schematic representation of experimental design. RNA harvested from CD16/32 HI and CD16/32 LO cells from IL-15 +/+ and IL-15 −/− TAX-LUC tail tumors were analyzed by array. B) Profiles of gene expression changes associated with the absence of IL-15 in CD16/32 HI and CD16/32 LO tumor cell populations.

    Article Snippet: For CD16/32 staining additional blocking steps with avidin D solution (Vector Laboratories) and for 15 min at room temp, followed by biotin for 15 minutes at room temperature was included prior to incubation in primary biotin rat anti-mouse CD16/32 antibody (BD Pharmingen) overnight at 4°C.

    Techniques: Expressing

    A) Images of IL-1α IHC in IL-15 +/+ (middle) and IL-15 −/− (right) TAX-LUC tumor sections compared to control lacking primary IL-1α antibody (left). B) The effect of anti-IL-1α antibodies (red curve, n = 5) on tumor growth compared to saline (black curve, n = 5) in IL-15 +/+ TAX-LUC mice over the course of 1 week. Error bars represent standard deviation of tumor growth, and p values represent 2-tailed, paired Student’s T Tests. The bar graph (right) represents FACS data obtained from anti-IL-1a treated tumors (red bars) or control tumors (black bars) at necropsy showing the abundance of CD8 + , CD4 + , CD16/32 HI , and CD16/32 LO cells present in the tumor at the experimental endpoint. Y axis is log scale and error bars represent standard deviation. C) The effect of Anakinra on tumor growth compared to saline. In 7 of 9 mice Anakinra resulted in repression of tumor growth (Anakinra R, red line), while in 2 of 9 mice Anakinra resulted in promotion of tumor growth (Anakinra P, blue line). Graph is double-Y to accommodate the scale differences between Anakinra R and control (left scale) versus Anakinra P (right scale). Red arrows indicate the time points of daily Anakinra injections, error bars represent standard deviations and p values represent 2-tailed, paired Student’s T Tests. The bar graph (right) represents FACS data obtained from Anakinra treated tumors or control tumors at necropsy showing the abundance of CD8 + , CD4 + , CD16/32 HI , and CD16/32 LO cells present in the tumor at the experimental endpoint. Y axis is log scale and error bars represent standard deviation.

    Journal: PLoS ONE

    Article Title: IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity

    doi: 10.1371/journal.pone.0085028

    Figure Lengend Snippet: A) Images of IL-1α IHC in IL-15 +/+ (middle) and IL-15 −/− (right) TAX-LUC tumor sections compared to control lacking primary IL-1α antibody (left). B) The effect of anti-IL-1α antibodies (red curve, n = 5) on tumor growth compared to saline (black curve, n = 5) in IL-15 +/+ TAX-LUC mice over the course of 1 week. Error bars represent standard deviation of tumor growth, and p values represent 2-tailed, paired Student’s T Tests. The bar graph (right) represents FACS data obtained from anti-IL-1a treated tumors (red bars) or control tumors (black bars) at necropsy showing the abundance of CD8 + , CD4 + , CD16/32 HI , and CD16/32 LO cells present in the tumor at the experimental endpoint. Y axis is log scale and error bars represent standard deviation. C) The effect of Anakinra on tumor growth compared to saline. In 7 of 9 mice Anakinra resulted in repression of tumor growth (Anakinra R, red line), while in 2 of 9 mice Anakinra resulted in promotion of tumor growth (Anakinra P, blue line). Graph is double-Y to accommodate the scale differences between Anakinra R and control (left scale) versus Anakinra P (right scale). Red arrows indicate the time points of daily Anakinra injections, error bars represent standard deviations and p values represent 2-tailed, paired Student’s T Tests. The bar graph (right) represents FACS data obtained from Anakinra treated tumors or control tumors at necropsy showing the abundance of CD8 + , CD4 + , CD16/32 HI , and CD16/32 LO cells present in the tumor at the experimental endpoint. Y axis is log scale and error bars represent standard deviation.

    Article Snippet: For CD16/32 staining additional blocking steps with avidin D solution (Vector Laboratories) and for 15 min at room temp, followed by biotin for 15 minutes at room temperature was included prior to incubation in primary biotin rat anti-mouse CD16/32 antibody (BD Pharmingen) overnight at 4°C.

    Techniques: Standard Deviation